Sotrovimab: a new therapeutic option in lung transplant
R. Gutiérrez-Larraya Sánchez-Andrade (Madrid, Spain), S. Aguado Ibáñez (Madrid, Spain), M. Erro Iribarren (Madrid, Spain), G. Padín Pico (Madrid, Spain), A. Amaral Corgo (Madrid, Spain), B. Baamonde Veiga (Madrid, Spain), M. Lopez Pando (Madrid, Spain), S. Salinas Castillo (Madrid, Spain), M. Aguilar Pérez (Madrid, Spain), R. Laporta Hernández (Madrid, Spain), P. Ussetti Gil (Madrid, Spain), B. Jara Chinarro (Madrid, Spain)
Source: International Congress 2022 – Fantastic beasts: where to find them and how to treat
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Gutiérrez-Larraya Sánchez-Andrade (Madrid, Spain), S. Aguado Ibáñez (Madrid, Spain), M. Erro Iribarren (Madrid, Spain), G. Padín Pico (Madrid, Spain), A. Amaral Corgo (Madrid, Spain), B. Baamonde Veiga (Madrid, Spain), M. Lopez Pando (Madrid, Spain), S. Salinas Castillo (Madrid, Spain), M. Aguilar Pérez (Madrid, Spain), R. Laporta Hernández (Madrid, Spain), P. Ussetti Gil (Madrid, Spain), B. Jara Chinarro (Madrid, Spain). Sotrovimab: a new therapeutic option in lung transplant. 3297
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|